Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Raised to $65 at BMO Capital

January 12, 2021 6:27 AM
BMO Capital analyst Matthew Luchini raised the price target on Gilead Sciences (NASDAQ: GILD) to $65.00 (from $62.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change